Johnson Financial Group Inc (Wisconsin)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-30
Closed -$1.88K 852
2026
Q1
$1.88K Hold
30
﹤0.01% 796
2025
Q4
$1.99K Sell
30
-19
-39% -$1.23K ﹤0.01% 816
2025
Q3
$3.3K Buy
+49
New +$3.88K ﹤0.01% 879
2024
Q4
Sell
-62
Closed -$4.16K 875
2024
Q3
$4.16K Buy
62
+28
+82% +$2.3K ﹤0.01% 814
2024
Q2
$3.85K Buy
34
+30
+750% +$3.79K ﹤0.01% 628
2024
Q1
$555 Hold
4
﹤0.01% 716
2023
Q4
$497 Buy
+4
New +$409 ﹤0.01% 831
2022
Q3
Sell
-32
Closed -$2K 673
2022
Q2
$2K Buy
+32
New +$2.92K ﹤0.01% 602
2021
Q1
Sell
-360
Closed -$33K 651
2020
Q4
$33K Buy
+360
New +$32.1K ﹤0.01% 362
2013
Q3
Sell
-892
Closed -$5K 679
2013
Q2
$5K Buy
+892
New +$4.27K ﹤0.01% 616

Other funds holding DXCM

Johnson Financial Group Inc (Wisconsin)'s DXCM Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) sold out of DexCom (DXCM) in Q2 2026, closing a stake of 30 shares — an estimated $1.88K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in DXCM in Q2 2013 and held it in 10 quarters. The position peaked at $33K in Q4 2020. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 30 DexCom shares in Q2 2026, an estimated $1.88K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in DexCom in Q2 2013 and held it in 10 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s DexCom position peaked at $33K in Q4 2020.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.